Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®) - Marx, N; Rosenstock, J; Kahn, S E (Diab Vasc Dis Res, 2015)
et al.